Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Phase 3 placebo-controlled trial to determine efficacy of the probiotic LGG for reducing acute treatment related GI toxicity in patients with GI malignancy with phase 1 safety lead-in.
Epistemonikos ID: 2039ddad20794dbff0f544230448619e2a1d2825
First added on: May 11, 2024